Angiotensin II Receptor Blockers and Celiac Disease

Details

Basic Details

Date Posted

Monday, January 16, 2012

Status

Complete

Medical Product

angiotensin II receptor blocker (ARB)

candesartan

eprosartan

irbesartan

losartan

olmesartan

telmisartan

valsartan

Health Outcome(s)

celiac disease

Description

Modular program-based one-time assessment of the risk of celiac disease associated with new use of angiotensin II receptor blockers (ARBs). Modular programs are adaptable standardized programs.

Deliverables (1)

Mini-Sentinel Angiotensin II Receptor Blockers and Celiac Disease

Additional Information

Additional Details

FDA Center

CDER

Study Type

Modular Program

Assessment Type

Exploratory Analyses

Data Sources

Mini-Sentinel Distributed Dataset (MSDD)